Article

barrons.com on 2020-12-02 21:25

Bullish Call on Danaher Stock Is Met With a Yawn

Danaher has “exposure to two of the fastest-growing end markets in biopharma and diagnostics,” Goldman analyst Matthew Sykes said.

Related news